Jupiter Research Capital (Asia) Ltd’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$642K Sell
3,598
-26,731
-88% -$4.37M 0.07% 303
2026
Q2
$4.55M Buy
+30,329
New +$3.3M 0.51% 40
2026
Q1
– Sell
-3,319
Closed -$339K – 867
2025
Q4
$339K Buy
+3,319
New +$297K 0.07% 375

Other funds holding GH

Jupiter Research Capital (Asia) Ltd's GH Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd reduced its Guardant Health (GH) stake by 88% in Q3 2026, selling an estimated $4.37M and leaving 3,598 shares worth $642K. The position accounts for 0.07% of the portfolio, ranked #303.

Jupiter Research Capital (Asia) Ltd first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.55M in Q2 2026. 621 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 3,598 shares of Guardant Health worth $642K as of Q3 2026.
  • Jupiter Research Capital (Asia) Ltd sold 26,731 Guardant Health shares in Q3 2026, an estimated $4.37M.
  • Guardant Health made up 0.07% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #303 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Guardant Health position peaked at $4.55M in Q2 2026.
  • 621 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.